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Background: Recent studies implicate individual differences in regulatory focus as contributing to self-regulatory
dysfunction, particularly not responding to positive outcomes. How such individual differences emerge, however, is
unclear. We conducted a proof-of-concept study to examine the moderating effects of genetically driven variation
in dopamine signaling, a key modulator of neural reward circuits, on the association between regulatory focus and
reward cue responsiveness.
Method: Healthy Caucasians (N=59) completed a measure of chronic regulatory focus and a probabilistic reward
task. A common functional genetic polymorphism impacting prefrontal dopamine signaling (COMT rs4680) was
evaluated.
Results: Response bias, the participants’ propensity to modulate behavior as a function of reward, was predicted by
an interaction of regulatory focus and COMT genotype. Specifically, self-perceived success at achieving promotion
goals predicted total response bias, but only for individuals with the COMT genotype (Val/Val) associated with
relatively increased phasic dopamine signaling and cognitive flexibility.
Conclusions: The combination of success in promotion goal pursuit and Val/Val genotype appears to facilitate
responding to reward opportunities in the environment. This study is among the first to integrate an assessment of
self-regulatory style with an examination of genetic variability that underlies responsiveness to positive outcomes in
goal pursuit.
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The concept of self-regulation describes a broad set of cog-
nitive and behavioral processes by which individuals pur-
sue their goals and respond dynamically to their perceived
progress toward them [1]. There is increasing evidence
that self-regulatory dysfunction constitutes a vulnerability
factor for mood disorders and related forms of psycho-
pathology [2,3]. Variability in goal pursuit strategies and
the effectiveness of those strategies reflect differences in
both top-down and bottom-up mechanisms as well as the
characteristics of the interpersonal context in which goals
are being pursued [4]. Although self-regulation has been* Correspondence: elena.goetz@duke.edu
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reproduction in any medium, provided the orstudied at multiple levels of analysis, little research has
examined how those mechanisms interact to influence
people’s responsiveness to opportunities for goal attain-
ment. Behavioral scientists are beginning to turn their at-
tention to interactions between psychological mechanisms
of self-regulation and neurobiological factors that underlie
goal pursuit [5]. In this proof-of-concept study, we sought
to examine the independent and interactive contributions
of a psychological construct relevant to self-regulation
of personal goal pursuit and a genetically-based neurobio-
logical individual difference that affects reward-related
cognitive processing. Specifically, we investigated whether
individual differences in regulatory focus – a preference
for pursuing desired end-states via strategic approach vs.
avoidance, and/or variation in prefrontal dopamine sig-
naling associated with COMT rs4680 genotype, predic-td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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responsiveness.
Regulatory focus and goal pursuit
Regulatory focus theory (RFT) [6,7] proposes two cogni-
tive/motivational systems for personal goal pursuit, the
promotion and prevention systems. Both systems serve
the purpose of pursuing positive end-states, but they dif-
fer in sensitivity to environmental cues as well as in goal
pursuit means and strategies. The promotion system
operates by approaching a match with the desired posi-
tive outcome and “making good things happen,” using
eagerness as a means of pursuit. The prevention system
operates by avoiding a mismatch with the positive out-
come and “keeping bad things from happening,” using
vigilance as a means of pursuit. RFT proposes that a his-
tory of success with one class of goal-pursuit strategies
would be expected to induce a bias toward using those
strategies, leading an individual to seek out contexts
where preferred goals and strategies would be available
[8]. RFT thus postulates stable individual differences in
goal responsiveness based on the individual’s history of
promotion and/or prevention socialization and goal pur-
suit experiences [9,10].
Individual differences in promotion and prevention
orientation have dissociable neural correlates. For ex-
ample, Eddington et al. [11] found that priming of in-
dividuals’ promotion (but not prevention) goals was
associated with activation of the left orbitofrontal cortex
(OFC), and magnitude of activation correlated with
strength of orientation to promotion goal pursuit. Thus,
relative preference for promotion goals is manifested in
intensity of neural responses to personalized cues for
such goals, suggesting that neurobiological differences
could moderate the association between regulatory focus
and sensitivity to cues for positive outcomes. Further-
more, chronic perceived failure to attain promotion
goals is associated with dysphoric symptoms (e.g., [12]),
and Eddington et al. [13] observed that individuals meet-
ing DSM-IV criteria for major depressive disorder ma-
nifested attenuated left OFC activation in response to
promotion goals. Thus, delineating the neurobiological
mechanisms associated with self-regulatory dysfunction
may provide new insights into the onset and mainte-
nance of mood disorders [14].
COMT genotype, dopaminergic signaling, and goal
pursuit
Several lines of research have established the role of do-
pamine (DA) signaling in a mesocorticostriatal circuit to
update reinforcement information, encode new reward
contingencies, and facilitate incentive motivation [15,16].
DA signaling in the prefrontal cortex (PFC) is also import-
ant for working memory and attentional processes [17],underlying its role in goal pursuit. A common functional
missense polymorphism (rs4680) in the gene for catechol-
O-methyltransferase (COMT) – an enzyme responsible
for the degradation of catecholamines including DA – is
known to affect PFC synaptic DA availability [18-20] as
well as relative DA signaling in the mesocorticostriatal cir-
cuit [21]. Specifically, the low-activity Methionine (Met)
allele of rs4680 results in relatively higher tonic dopamine
levels in the PFC, facilitating sustained DA firing and
improved maintenance of activity states, as well as a
higher threshold to switch activity states. In contrast, the
Valine (Val) allele is associated with relatively decreased
tonic PFC DA, and higher phasic activity in mesocorticos-
triatal circuits [21].
Several studies have probed moderating effects of
rs4680 on mechanisms of self-regulation, including execu-
tive control, learning and adaptability, and affective pro-
cessing. Both the Met and Val alleles are associated with
improved performance and processing efficiency in diffe-
rent contexts, representing a trade-off in functionality
[22,23]. Research on task switching and reversal learning
has found that the Met/Met genotype is associated with
increased cognitive stability while the Val/Val genotype is
associated with increased cognitive flexibility [24,25].
Thus, the Met allele is associated with improved executive
cognition, more efficient PFC function [26], increased at-
tentional control (e.g., [27]), as well as reward-related acti-
vation in the PFC [28,29]. In contrast, the Val allele is
associated with better adaptability to new contingencies
and efficient shifting between informational states, allo-
wing for better reversal learning and serving a protective
function against stress and negative affect in the face of
failure (e.g., [30,31]). However, the association between
rs4680 genotype and reward responding is not straightfor-
ward: Val allele carriers have been found to better dif-
ferentiate win and loss experiences, which can facilitate
learning (e.g., [32]), while Met allele carriers have been
shown to have potentiated responsiveness to rewards due
to higher DA availability (e.g., [29,33]).
Given the importance of task parameters and moti-
vational context in determining which allele is advanta-
geous for regulating goal pursuit, a main effect of rs4680
genotype is unlikely. There is no particular rs4680 geno-
type that is uniformly advantageous across circum-
stances and no categorical “risk” genotype; instead, the
particular mechanisms, tendencies, and vulnerabilities
associated with each genotype are best considered as a
trade-off where the outcome depends on the contingen-
cies in the environment. Both proximal and long-term
environmental conditions interact with genetic variabil-
ity to produce particular context-specific advantages and
disadvantages in task performance, behavior, and affect.
A similar cost/benefit framework can be found in psy-
chological theories of self-regulation, such as RFT. For
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and have different styles and strategies of pursuing their
goals. They also differ in their responsiveness to feedback
about their strategies and their resilience in the face of
set-backs. These individual differences may prove to be
adaptive or maladaptive depending on the circumstances
in which goal pursuit occurs.
Given the commonality that psychological mechanisms
of self-regulation and underlying behavioral genetics both
frequently involve trade-offs, it is essential to integrate be-
havioral theories of individual differences in goal pursuit
with knowledge about underlying genetic variability. In
particular, these factors are likely to interact to produce
responses to reward not predictable from either mecha-
nism alone, and potentially constitute pathways to disor-
dered behavior and psychopathology. The present study
examined whether the interaction between rs4680 geno-
type and individual differences in regulatory focus pre-
dicted responses to cues for reward.
Modeling the interactive effects of regulatory focus and
COMT genotype
To measure reward responsiveness, we selected a well-
validated laboratory probabilistic reward task designed
to provide an experimentally-derived operationalization
of reward responsiveness and learning. This task has
been used to assess reward responsiveness in healthy
populations [34], individuals under stress [35,36], and
individuals with depression [37]. In this task, reward res-
ponsiveness is operationalized as the tendency to prefe-
rentially select a more frequently rewarded stimulus and
thus to develop a response bias.
The task offers several advantages as an index of res-
ponsiveness to cues for goal attainment. First, it has
been characterized as a signal detection task (e.g., [34]),
and the signal detection framework has been previously
applied to describe the promotion and prevention sys-
tems [38,39]. Individuals in a promotion focus seek to
achieve “hits” and ensure against errors of omission,
resulting in a bias of saying “yes” to a cue that might sig-
nify an opportunity for reward. Conversely, individuals
in a prevention focus are concerned with making correct
rejections and ensuring against errors of commission,
resulting in a bias of saying “no” to a potential reward
and avoiding incorrect responses. This task in particu-
lar is promotion-consistent because the goal is to earn
money (rather than to “avoid losing” money) and the
payoff structure is framed as gain versus non-gain. Since
promotion focus entails a preference for opportunities to
make good things happen and a relative attention to cues
for reward as well as increased use of approach strategies,
the task is a “fit” [7] for a chronic orientation toward pro-
motion goals. Second, the task has been shown to
measure reward-related cognitive processes directlyrelevant to self-regulation of goal pursuit, such as
responding to positive feedback and capitalizing on
opportunities for gain [34]. Finally, the task provides
an efficient way to quantify goal-directed behavior,
namely, an accumulation of trial-by-trial responding
in pursuit of monetary rewards.
We hypothesized that individual differences in promo-
tion system strength would predict reward-related behavior
in our experimental task. However, we also hypothesized
that DA signaling in the PFC as modeled by rs4680 geno-
type would moderate the association between promotion
goal pursuit orientation and reward learning. Specifically,
we predicted that the rs4680 Val allele would be associa-
ted with greater behavioral modulation and flexibility in
reward-responsive behavior for individuals with different
experiences of promotion goal pursuit. On the other hand,
we predicted that the rs4680 Met allele would be asso-
ciated with a more stable profile of reward responsiveness,




To minimize possible population stratification due to
different rs4680 allele frequencies across ethnic groups,
our study sample was restricted to Caucasian partici-
pants. Study participants (N=67) were recruited via on-
campus flyers. All participants were healthy volunteers
between 18 and 30 years of age and were self-reported
non-smokers, due to previous reports that nicotine has
significant effects on reward responsiveness as assessed
by the current probabilistic reward task [40]. Partici-
pants provided written informed consent, were com-
pensated $10 per hour, and earned a pre-determined
amount between $5.80 and $6.20 in the computer task.
Four participants were excluded for non-compliance
(N=3) or computer malfunction (N=1). One subject was
excluded due to high levels of depressive symptoms, and
three subjects were excluded from analyses due to outlier
scores (see Data Analysis section for details). Thus,
complete and valid data were available for N=59 subjects
(35 female). The participants had a mean age = 21.3 ± 2.7
and 92% were right-handed as per self-report. The par-
ticipants were generally free of psychological distress
(mean Beck Depression Inventory-II (BDI-II) score = 5.93,
SD = 4.86, range = 1 to 18), although information about
medication use and psychiatric history was not collected.
Procedures
Participants completed the 20-min probabilistic reward
task and a set of self-report questionnaires, including the
Regulatory Focus Questionnaire (RFQ) [8], the BDI-II
[41], and the trait version of the Positive and Negative
Affect Schedule (PANAS) [42]. In addition, participants
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were approved by the Duke University Institutional Review
Board for Non-Medical Research.
Probabilistic reward task
This computerized task is a probabilistic reward-based
learning paradigm where participants are asked to identify
which of two stimulus images is being presented on each
trial. This task has been described in detail elsewhere
(e.g., [34]) and has been adopted from Tripp and Alsop
[43]. Briefly, participants are instructed press a button on
the keyboard to indicate whether a long (13 mm) or short
(11.5 mm) mouth is presented (100 ms) within a sche-
matic face. They are told that for some of their correct
responses, they will receive a monetary reward of 5 cents.
One of the images is rewarded more frequently, with a 3:1
reward ratio between the “rich” stimulus and the “lean”
stimulus. The task consists of three blocks of 100 trials
each, with up to 40 trials per block receiving a reward.
The two mouth types are presented with equal frequency,
but, unknown to the participants, the reward feedback is
asymmetrical in favor of the “rich” stimulus (30 rich versus
10 lean rewards). This paradigm has been found to reliably
produce a response bias such that as the task proceeds,
the “rich” or more frequently rewarded stimulus is prefe-
rentially selected [34,36].
Response bias and discriminability scores were calcu-













Both formulae were adjusted by adding 0.5 to each
value of correct or incorrect responses to eliminate zero
values in the denominator (see [37]). Discriminability
scores were used to ensure that any findings observed
for response bias were not artifacts of task difficulty or
individual variability in skill. Response bias towards the
more frequently rewarded stimulus can be interpreted as
the degree to which an individual engages in the task
based on her/his reinforcement history, and as an index
of the capacity to respond to reward information and
maintain the bias even when reinforcement is intermit-
tent [34,43]. A high response bias results if a participant
has a high hit rate for the rich stimulus and a high miss
rate for the lean stimulus, reflecting a strategy where
participants try to ensure “hits” where they are rewarded
for their response (gains), and to ensure against errors of
omission (non-gains).
To capture participants’ propensity to modulate behavior
as a function of prior reward, total response bias across the
three blocks of the task was used as the outcome variable.Bias and discriminability were calculated across all valid
trials, defined as one where the response reaction time
(RT) was between 150 and 2500 msec, and the natural log
transformation of RT was within 3 standard deviations of
the mean for each participant, as in previous studies using
this task (e.g., [34]). A total of 1.43% of the trials were
excluded.
Individual differences in regulatory focus
The Regulatory Focus Questionnaire (RFQ) [8] is a 22-item,
self-report Likert-style measure designed to assess indivi-
dual differences in orientation toward promotion and pre-
vention. The questionnaire has four subscales, two that
measure individuals’ recollection of their early experiences
in being oriented toward a promotion or prevention focus
by their parents (“history” subscales), and two that measure
individuals’ subjective assessment of their experiences
achieving goals of either a promotion or prevention nature
(“success” subscales). Sample items include “My parents
encouraged me to try new things” (promotion history), “My
parents kept order in our house by having a lot of rules and
regulations for me” (prevention history), “I feel like I have
made progress towards being successful in life” (promotion
success), and “Not being careful enough has gotten me into
trouble at times” (prevention success, reverse-scored). Res-
ponses are made on a 5-point scale ranging from “never or
seldom” or “certainly false” to “very often” or “certainly
true,” and the item responses within each subscale are ave-
raged to produce four scores: promotion history, preven-
tion history, promotion success, and prevention success.
Higgins et al. [8] reported good internal reliability for the
promotion success scale (α = 0.73) and prevention success
scale (α = 0.80), and the scales showed a two month test-
retest reliability of 0.79 correlation or higher. There are no
published psychometric data for the history scales, although
in the current sample, the reliability scores for the history
subscales were α = 0.70 for promotion history, and α = 0.80
for prevention history.
Genotyping
Saliva samples were collected via Oragene kits (Oragene,
DNA Genotek; Ottawa, Ontario, Canada). The samples
were purified and DNA was extracted and rehydrated
according to standard protocols (www.dnagenotek.com).
Genotyping of rs4680 was performed using TaqMan
allele-specific polymerase chain reaction (PCR) as per
Caspi et al. [44]. All genotype calls were ascertained by
two independent raters using sequence verified stan-
dards with 100% agreement.
Data analysis
Extreme response bias scores (>3 standard deviations
from the mean) of two participants were removed to im-
prove the normality of the data. One participant had two
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from the mean and these exerted moderate to high in-
fluence on the association of those subscale scores and
response bias scores. To prevent statistical distortion
due to these outlier scores, this participant was also
removed from the final analyses. Genotypes were coded
as the number of Met alleles for rs4680.
Results
Distribution of genotypes in the sample
The sample was split into three groups on the basis of
genotype: Met/Met (N=14, 24% of sample), Val/Met
(N=28, 47%), and Val/Val (N=17, 29%). The three groups
were in Hardy-Weinberg equilibrium (χ2(2)=.14, p=.93).
The Pearson correlations among the RFQ scores,
PANAS trait scores, and response bias are displayed in
Table 1.
Discriminability and accuracy
A set of regression analyses examined whether any of
the RFQ variables or genotypes predicted total discrimi-
nability or accuracy scores as main effects or interactions,
and all models and interaction effects were non-significant
(all p > .1).
Regulatory focus and genotype predicting response bias
We conducted a series of analyses to determine whether
individual differences in regulatory focus and/or COMT
rs4680 genotype predicted total response bias on the re-
ward task. First, a one-way ANOVA was performed to
examine whether response bias differed by genotype
group; this test was not significant (F(2, 56) = 0.52, p > .5).
In addition, ANOVAs were performed to examine whether
any of the regulatory focus variables differed by genotypeTable 1 Correlation matrix for study variables
Promotion history Prevention success









* p<.05, ** p<.01; PANAS = Positive and Negative Affect Schedule, PA = Positive Affgroup, using a Bonferroni correction to control for Type 1
error (4 tests, α threshold =.0125). Only prevention his-
tory was found to differ by rs4680 group, F(2,56) = 4.73,
p < .05. A post-hoc Tukey pairwise comparison test
revealed that the rs4680 Val/Val group had significantly
higher prevention history scores than the Val/Met group
(group means = 4.17 versus 3.56 respectively, p < .05) but
not the Met/Met group (group mean = 4.11, p > .9). See
Table 2 for descriptive statistics of key study variables by
COMT rs4680 genotype group.
Next, hierarchical regression analysis was used to test
the prediction that regulatory focus and rs4680 genotype
interacted to predict response bias. In the first step, the
four RFQ variables were entered. This step was non-sig-
nificant, F(4, 54) = .56, p = .69, and all βs were non-
significant (all p > .4). In the second step, rs4680 genotype
was added to the model but did not significantly improve
fit, ΔF(1, 53) = 1.04, p = .31. For the third step, the RFQ
variables were mean-centered and regulatory focus
X rs4680 interaction terms were created. Each interaction
term was entered into the model to evaluate its unique
contribution above the main effects of all RFQ variables
and the main effect of rs4680. The interaction terms for
prevention history, promotion history, and prevention
success did not provide significant incremental improve-
ment in model fit: all ΔF p > .60. However, the promotion
success X rs4680 interaction was a significant predictor
of response bias: ΔF(1, 52) = 4.13, p < .05, ΔR2 = 0.07
(see Additional file 1: Table S1). In a reduced model where
only promotion success, rs4680 genotype, and the inter-
action were entered, the overall model fit was marginally
significant: F(3, 55) = 2.39, p < .08, R2 = 0.12.
Next, the promotion success X rs4680 interaction was
decomposed by dividing the sample into genotypePromotion success PANAS PA PANAS NA Total RB
-.34** -.11 -.33* -.13
p=.008 p>.1 p=.012 p>.1
.15 .27* -.26* -.07
p>.1 p=.038 p=.048 p>.1
.74** .11 -.04 .13








ect, NA = Negative Affect, RB = Response Bias.















Val/Val 4.17 (0.58) 3.81 (0.93) 2.92 (0.99) 3.29 (0.86) 5.00 (3.94) 32.06 (6.16) 13.41 (4.17) 0.11 (0.15)
Val/Met 3.56 (0.78) 3.99 (0.68) 2.93(1.04) 3.39 (0.81) 6.93 (5.13) 34.46 (5.47) 14.29 (3.79) 0.11 (0.14)
Met/Met 4.11 (0.78) 4.13 (0.59) 2.87(1.15) 3.25 (1.14) 5.07 (5.24) 32.50 (6.43) 13.57 (3.80) 0.16 (0.18)
PANAS = Positive and Negative Affect Schedule, PA = Positive Affect, NA = Negative Affect, RB = Response Bias.
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promotion success and response bias within each group.
These regression analyses revealed that a significant as-
sociation between promotion success and response bias
was present only in the Val/Val genotype group: F(1, 15)
= 9.85, p < .01, adjusted R2 = .36. The Val/Met and Met/
Met groups did not manifest any association between
promotion success and response bias (both F < .15; see
Figure 1).
Finally, a tertiary split was performed on promotion suc-
cess scores in order to compare mean response bias across
the range of promotion success. The COMT rs4680 geno-
type groups Val/Met and Met/Met were combined. Total
response bias was significantly lower for the Val/Val group
compared to Met allele carriers in the lowest third of pro-
motion scores, t(18) = −2.30, p = .034 (Additional file 2:
Figure S1). There were no significant differences in re-
sponse bias across genotype groups between those partici-
pants in the middle (p > .82) or highest third (p > .50) of
promotion success.
Discussion
The goal of this proof-of-concept study was to examine
how regulatory focus and a common functional poly-
morphism affecting DA signaling predicted behavior in aFigure 1 Total response bias as a function of promotion success scor
predicted response bias only for the Val/Val participants, p < .01, adjusted Rprobabilistic reward task. The results confirmed our hy-
pothesis that rs4680 genotype, which biases COMT func-
tion and associated DA signaling in the PFC, moderates
the degree to which a particular pattern of self-regulatory
success experiences affects reward responsiveness. Specifi-
cally, our results showed that the combination of success
in promotion goal pursuit and Val/Val genotype appears
to facilitate responding to reward opportunities in the en-
vironment. On the other hand, Met allele carriers did not
show an association between regulatory success in pursu-
ing promotion goals and developing a reward-related re-
sponse bias in our task.
Research examining the nature and consequences of
self-regulation may provide a context for interpreting the
present findings, both from the perspective of basic science
and in regard to potential pathways of vulnerability for
mood disorders. For example, we suggest that it is im-
portant to recognize that the observed associations among
regulatory focus, rs4680 genotype, and reward responsive-
ness are not readily apparent at the phenotypic level. There
was no broad association found between rs4680 genotype
and self-regulatory style. This finding is consistent with
previous research indicating that regulatory orientation is
primarily shaped by accumulated experience with success
or failure in goal pursuit and is independent fromR2 = 0.36
R2 < 0.01
R2 = 0.01
e, across COMT rs4680 genotype groups. Promotion success
2 = .36.
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the fact that variability in both mechanisms involves trade-
offs that manifest in context-specific ways.
In this study, we hypothesized that an interaction of
rs4680 genotype and self-regulatory style would result in
predictable effects on responses to probabilistic reward
feedback. The reward task yielded a reliably quantifiable
measure of reward responsiveness, that is, participants’
propensity to modulate behavior as a function of prior
reward. Individuals who are more responsive to reward
feedback will preferentially select the more frequent-
ly rewarded stimulus and thus manifest a stronger res-
ponse bias across the task. As noted previously, the task
is promotion-consistent because outcomes are presented
to participants as gain/non-gain – to earn money (in-
stead of to “avoid losing” money). Therefore, individuals
who believe that they are successful at achieving promo-
tion goals should manifest a response bias that favors
the more rewarded or “rich” stimulus. Interestingly, we
did not observe a main effect of rs4680 genotype or pro-
motion orientation on reward responsiveness. Rather,
the effect of a history of promotion success on reward
responsiveness was found to be moderated by rs4680
genotype (specific to the Val/Val genotype group).
The pattern of findings revealed a terminative inter-
action, where among individuals reporting relatively low
levels of success pursuing promotion goals, the Val/Val
genotype was associated with significantly lower res-
ponse bias than in Met allele carriers. However, among
individuals reporting frequent success experiences in the
promotion domain, the Val/Val genotype was associated
with mean response bias that did not significantly differ
than that observed for Val/Met or Met/Met genotypes.
Self-reported promotion success did not predict response
bias among Val/Met or Met/Met genotypes, which also did
not differ from each either. Thus, no Met allele dose effect
was observed either as a main effect or as an interaction.
This pattern of results corresponds with the trade-off
framework for interpreting COMT-related variability in re-
ward sensitivity that was described above. The Val/Val indi-
viduals who reported low levels of promotion success
demonstrated significantly lower total response bias scores
than Met allele carriers. There is the possibility that Val/Val
individuals are more susceptible to fluctuations in DA
when rewards are omitted and therefore have greater dif-
ficulty integrating reward-related information over time.
This would be an example of flexibility and behavioral
adaptability being disadvantageous within a particular con-
text, and such a neurobiological profile would be especially
maladaptive given a personal history of low promotion suc-
cess. Thus, Val/Val individuals with low promotion success
might constitute a group of individuals who would be par-
ticularly vulnerable to anhedonia or reward insensitivity in
the face of chronic promotion failure experiences. There isevidence that Val/Val individuals show decreased respon-
siveness to reinforcers [28,29], and reduced motivational
drive to pursue reinforcers would interfere with successful
promotion goal pursuit.
The fact that Met allele carriers did not show modula-
tion of their response bias based on their degree of success
in pursuing their promotion goals fits with a “resilience”
model. Even in the context of low promotion success,
individuals with higher tonic PFC dopamine (Met allele
carriers) did not manifest low levels of reward-responsive
behavior. However, there is a competing interpretation:
that Met allele carriers are not able to increase reward-
related responding based on their previous goal-pursuit
experiences, which might adversely affect the pursuit of
promotion goals. Such an alternative hypothesis is con-
sistent with previous findings of cognitive [24,25] and
affective [30] inflexibility associated with the Met allele.
There may be some relative deficits in reward-related
responding for Met allele carriers who have had successful
self-regulatory experiences, because those individuals with
high promotion success scores exhibited only average res-
ponse bias scores. The Met allele carriers might have an
inability to update or adapt behavior via reward feedback
that could create some vulnerability in the face of future
self-regulatory challenges or failure experiences.
The results from this study illustrate that an integrative
approach to COMT variability and self-regulation has the
potential to reveal novel pathways of psychological vulne-
rability. Self-regulation involves a complex set of processes
including goal selection and pursuit, cognitive and emo-
tional control, and ongoing decision-making [45]. Factors
such as reward responsiveness, impulsivity/distractibility,
and affective resilience can impact how goals are pursued
and how feedback about progress is managed, and individ-
ual variability in COMT has been shown to affect all of
these processes. A research strategy that applies individual
differences information from genetic sources to studies of
ongoing, situationally-embedded self-regulation might yield
context-sensitive examples of when these processes break
down and produce regulatory dysfunction and, possibly,
clinical disorders.
Regions in the PFC, particularly the OFC, are involved
in responsiveness to motivationally salient feedback and
shifts in goal pursuit originating from bottom-up processes
(e.g., [28]) as well as top-down processes (e.g., [11]). Thus,
the OFC is likely to be a site that mediates the interaction
between individual differences in regulatory focus and
rs4680 genotype to produce reward-related behavior, and at
least one study [13] has observed that clinically depressed
individuals manifest attenuated left OFC activation in re-
sponse to their own promotion goals.
The significant interaction between promotion success
and rs4680 genotype was detected even in the hierarchical
multiple regression models that included other regulatory
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cularly important to differentiate promotion success from
prevention success, which were substantially correlated
(r=.74, p<.001). Despite the intercorrelation, it was success
in attaining promotion goals, and not successful preven-
tion goal attainment, that predicted reward responsiveness
for the Val/Val genotype. RFT postulates fundamental dif-
ferences between the promotion and prevention systems
with regard to the targets of goal pursuit (e.g., “ideals” vs.
“oughts”), the strategies used to pursue them (“making
good things happen” vs. “keeping bad things from happen-
ing”), and the motivational impetus that underlies goal
pursuit (eagerness vs. vigilance). These behavioral and
cognitive distinctions appear to be accompanied by diffe-
rences in cortical activation when promotion vs. preven-
tion goals are primed [11,13], although additional research
is needed to characterize the shared and unique neural
circuitry associated with these two hypothetical cognitive/
motivational systems. Such research, in combination with a
genetic/neurobiological level of analysis, could help to elu-
cidate pathways by which self-regulatory dysfunction could
lead to the onset and maintenance of mood disorders.
There are several limitations of this study that should
be acknowledged. First, the relatively small sample size
leaves us vulnerable to statistical noise including false
positives. However, this is more problematic in the ab-
sence of significant effects (i.e., false negatives), which
could simply reflect inadequate power, and thus one
should use caution when interpreting non-significant
results such as the lack of main effects. The fact that we
found significant effects robust to the influence of cova-
riates suggests the observed interaction between self-
regulatory style and rs4680 genotype is valid. Neverthe-
less, replication of the effects described herein is neces-
sary to further the possible utility of our interaction
model for understanding clinically relevant outcomes (e.
g., risk for mood disorders). Second, because the genetic
analyses were restricted to a Caucasian-only sample,
generalizability may be limited. It will be of interest to
examine this effect in non-Caucasian samples. Third, al-
though the task provided a well-validated operationaliza-
tion of the experience of responding to reward feedback,
its external validity as a proxy of goal pursuit behavior is
understandably limited. Previous studies of the neurobio-
logical substrates underlying regulatory focus relied on
idiographic stimuli that captured individuals’ personal
goals [11,13], and the degree to which earning money was
a goal of the participants in this study was implied by their
participation but not explicitly verified. A future study
could extend these findings by obtaining genetic informa-
tion on participants who undergo neuroimaging when
exposed to their goals, or using another kind of goal-
pursuit task such as anagram solving that is related to per-
severance and conscious decision-making about effort andmotivation. In addition, a future exploration of these
effects should include measures of potential important
contributory variables such as stressful life events (particu-
larly during development) and state-level anxiety, as these
both could impact the development and manifestation of
one’s regulatory focus.
Conclusions
This study used a research strategy that integrated neuro-
biological variability (as indexed by a common functional
genetic polymorphism) and trait-like differences in cogni-
tive/motivational systems to predict reward-related beha-
vior in a novel way. Our findings showed that – consistent
with a trade-off model – rs4680 genotype interacts with
self-regulatory success experiences to predict reward res-
ponsive behavior only in individuals with a Val/Val geno-
type, and this pattern could be adaptive at high levels of
success or maladaptive at low levels of success. By con-
trast, the response profiles of Met allele carriers indicated
that previous goal pursuit success does not impact their
development of a reward-related response bias. Our ap-
proach extends our understanding of how top-down self-
regulatory mechanisms affect behavior by examining the
moderating influence of bottom-up biological mecha-
nisms. This interaction of mechanisms and methodologies
is likely to be a fruitful avenue of future inquiry to elabo-
rate the individual differences affecting complex behaviors
and psychiatric phenotypes, such as reward dysfunction in
depression or addiction [46].
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Abbreviations
(RFT): Regulatory focus theory; (COMT): Catechol-o-methyltransferase;
(DA): Dopamine; (RFQ): Regulatory Focus Questionnaire.
Competing interests
DAP has received consulting fees from ANT North America Inc. (Advanced
Neuro Technology), AstraZeneca, Shire, and Ono PharmaUSA, and honoraria
from AstraZeneca for studies unrelated to this project. The authors declare
that they have no other competing interests.
Authors’ contributions
ELG helped conceive of the design of the study, collected data and
conducted genotyping, performed data analysis, and took the lead on
writing the manuscript. ARH helped conceive of the design of the study,
oversaw genetic analysis, and contributed to writing the manuscript. DAP
contributed to the design of the study and data interpretation, as well as
consulted on the implementation of the experimental task and provided
feedback on the manuscript. TJS helped conceive of the design of the study,
contributed to data analysis, and contributed to writing the manuscript. All
authors read and approved the final manuscript.
Goetz et al. Biology of Mood & Anxiety Disorders 2013, 3:3 Page 9 of 10
http://www.biolmoodanxietydisord.com/content/3/1/3Acknowledgements
The authors would like to thank Yuliya Nikolova, Karen Sugden, and Ben
Williams for their assistance with genotyping, and Matthew Hoyle for his
assistance with data collection. This work was supported by the National
Institute on Drug Abuse [R01 DA031579 to Timothy J. Strauman, which is
supported by the NIH Common Fund and managed by the OD/Office of
Strategic Coordination, and P30 DA023026 to Kenneth Dodge and Philip
Costanzo]; by Duke University funding to Ahmad R. Hariri; and an NSF
Graduate Research Fellowship to Elena L. Goetz.
Author details
1Department of Psychology & Neuroscience, Duke University, Durham, NC,
USA. 2Institute for Genome Sciences and Policy, Duke University, Durham,
NC, USA. 3Department of Psychiatry, Harvard University Medical School,
Boston, MA, USA.
Received: 27 July 2012 Accepted: 14 November 2012
Published: 1 February 2013
References
1. Carver CS, Scheier MF: Origins and functions of positive and negative
affect: a control- process view. Psychol Rev 1990, 97:19–35.
2. Karoly P: Mechanisms of self-regulation: a systems view. Annu Rev Psychol
1993, 44:23–52.
3. Strauman TJ: Self-regulation and depression. Self and Identity 2002, 1:151–157.
4. Strauman TJ, Wilson WA: Individual differences in approach and
avoidance: Behavioral activation/inhibition and regulatory focus as
distinct systems. In Handbook of Self- Regulation and Personality. Edited by
Hoyle R. New York: Guilford Press; 2010:447–473.
5. Carver CS, Johnson SL, Joormann J: Two-mode models of self-regulation
as a tool for conceptualizing effects of the serotonin system in normal
behavior and diverse disorders. Curr Dir Psychol Sci 2009, 18:195–199.
6. Higgins ET: Beyond pleasure and pain. Am Psychol 1997, 52:1280–1300.
7. Higgins ET: Promotion and prevention: Regulatory focus as a
motivational principle. In Advances in Experimental Social Psychology,
Volume 30. Edited by Zanna MP. New York: Academic; 1998,1–46.
8. Higgins ET, Friedman RS, Harlow RE, Idson LC, Ayduk ON, Taylor A:
Achievement orientations from subjective histories of success:
promotion pride versus prevention pride. Eur J Soc Psych 2001, 31:3–23.
9. Manian N, Papadakis AA, Strauman TJ, Essex MJ: The development of
children's ideal and ought self-guides: parenting, temperament, and
individual differences in guide strength. J Pers 2006, 74:1619–1645.
10. Strauman TJ: Stability within the self: a longitudinal study of the implications
of self-discrepancy theory. J Pers Soc Psychol 1996, 71:1142–1153.
11. Eddington KM, Dolcos F, Cabeza R, Krishnan KRR, Strauman TJ: Neural
correlates of promotion and prevention goal activation: an fMRI study
using an idiographic approach. J Cogn Neurosci 2007, 19:1152–1162.
12. Miller AK, Markman KD: Depression, regulatory focus, and motivation.
Pers Individ Dif 2007, 43:427–436.
13. Eddington KM, Dolcos F, McLean AN, Cabeza R, Krishnan KRR, Strauman TJ:
Neural correlates of idiographic goal priming in depression: goal-specific
dysfunctions in the orbitofrontal cortex. Soc Cogn Affect Neurosci 2009,
4:238–246.
14. Hasler G, Drevets WC, Manji HK, Charney DS: Discovering endophenotypes
for major depression. Neuropsychopharmacology 2004, 29:1765–1781.
15. Depue RA, Collins PF: Neurobiology of the structure of personality:
dopamine, facilitation of incentive motivation, and extraversion.
Behav Brain Sci 1999, 22:491–517.
16. Schultz W: Getting formal with dopamine and reward. Neuron 2002,
36:241–263.
17. Goldman-Rakic PS, Muly EC III, Williams GV: D(1) receptors in prefrontal
cells and circuits. Brain Res Rev 2000, 31:295–301.
18. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS,
Hyde TM, Herman MM, Apud J, Egan MF, Kleinman JE, Weinberger DR:
Functional analysis of genetic variation in catechol-O-methyltransferase
(COMT): effects on mRNA, protein, and enzyme activity in postmortem
human brain. Am J Hum Genet 2004, 75:807–821.
19. Matsumoto M, Weickert CS, Akil M, Lipska BK, Hyde TM, Herman MM,
Kleinman JE, Weinberger DR: Catechol O-methyltransferase mRNA
expression in human and rat brain: evidence for a role in corticalneuronal function. Neuroscience 2003, 116:127–137.
20. Tunbridge EM, Harrison PJ, Weinberger DR: Catechol-o-methyltransferase,
cognition, and psychosis: Val158Met and beyond. Biol Psychiatry 2006,
60:141–151.
21. Bilder RM, Volavka J, Lachman HM, Grace AA: The catechol-O-
methyltransferase polymorphism: relations to the tonic-phasic dopamine
hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology
2004, 29:1943–1961.
22. Barnett JH, Scoriels L, Munafò MR: Meta-analysis of the cognitive effects of
the catechol-O-methyltransferase gene val158/108met polymorphism.
Biol Psychiatry 2008, 64:137–144.
23. Mier D, Kirsch P, Meyer-Lindenberg A: Neural substrates of pleiotropic
action of genetic variation in COMT: a meta-analysis. Mol Psychiatry 2010,
15:918–927.
24. Colzato LS, Waszak F, Nieuwenhuis S, Posthuma D, Hommel B: The flexible
mind is associated with the catechol-O-methyltransferase (COMT)
Val158Met polymorphism: evidence for a role of dopamine in the control
of task-switching. Neuropsychologia 2010, 48:2764–2768.
25. Krugel LK, Biele G, Mohr PN, Li SC, Heekeren HR: Genetic variation in
dopaminergic neuromodulation influences the ability to rapidly and
flexibly adapt decisions. Proc Natl Acad Sci USA 2009, 106:17951–17956.
26. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE,
Goldman D, Weinberger DR: Effect of COMT Val108/158 Met genotype on
frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA
2001, 98:6917–6922.
27. Blasi G, Mattay VS, Bertolino A, Elvevåg B, Callicott JH, Das S, Kolachana BS,
Egan MF, Goldberg TE, Weinberger DR: Effect of catechol-O-
methyltransferase val158met genotype on attentional control. J Neurosci
2005, 25:5038–5045.
28. Dreher JC, Kohn P, Kolachana B, Weinberger DR, Berman KF: Variation in
dopamine genes influences responsivity of the human reward system.
Proc Natl Acad Sci USA 2009, 106:617–622.
29. Yacubian J, Sommer T, Schroeder K, Gläscher J, Kalisch R, Leuenberger B,
Braus DF, Büchel C: Gene-gene interaction associated with neural reward
sensitivity. Proc Natl Acad Sci 2007, 104:8125–8130.
30. Drabant EM, Hariri AR, Meyer-Lindenberg A, Munoz KE, Mattay VS,
Kolachana BS, Egan MF, Weinberger DR: Catechol O-methyltransferase
val158met genotype and neural mechanisms related to affective arousal
and regulation. Arch Gen Psychiatry 2006, 63:1396–1406.
31. Smolka MN, Schumann G, Wrase J, Grüsser SM, Flor H, Mann K, Braus DF,
Goldman D, Büchel C, Heinz A: Catechol-O-methyltransferaseval158met
genotype affects processing of emotional stimuli in the amygdala and
prefrontal cortex. J Neurosci 2005, 25:836–842.
32. Camara E, Krämer UM, Cunillera T, Marco-Pallarés J, Cucurell D, Nager W, Mestres-
Missé A, Bauer P, Schüle R, Schöls L, Tempelmann C, Rodriguez-Fornells A, Münte
TF: The effects of COMT (Val108/158Met) and DRD4 (SNP −521) dopamine
genotypes on brain activations related to valence and magnitude of rewards.
Cereb Cortex 2010, 20:1985–1996. doi:10.1093/cercor/bhp263.
33. Schmack K, Schlagenhauf F, Sterzer P, Wrase J, Beck A, Dembler T, Kalus P,
Puls I, Sander T, Heinz A, Gallinat J: Catechol-O-methyltransferase
val158met genotype influences neural processing of reward
anticipation. Neuroimage 2008, 42:1631–1638. doi:10.1016/j.
neuroimage.2008.06.019.
34. Pizzagalli DA, Jahn AL, O'Shea JP: Toward an objective characterization of
an anhedonic phenotype: a signal-detection approach. Biol Psychiatry
2005, 57:319–327.
35. Bogdan R, Pizzagalli DA: Acute stress reduces reward responsiveness:
implications for depression. Biol Psychiatry 2006, 60:1147–1154.
36. Pizzagalli DA, Bogdan R, Ratner KG, Jahn AL: Increased perceived stress is
associated with blunted hedonic capacity: potential implications for
depression research. Behav Res Ther 2007, 45:2742–2753.
37. Pizzagalli DA, Iosifescu D, Hallett LA, Ratner KG, Fava M: Reduced hedonic
capacity in major depressive disorder: evidence from a probabilistic
reward task. J Psychiatr Res 2008, 43:76–87.
38. Crowe E, Higgins ET: Regulatory focus and strategic inclinations:
promotion and prevention in decision-making. Organ Behav Hum Decis
Process 1997, 69:117–132.
39. Cunningham WA, Raye CL, Johnson MK: Neural correlates of evaluation
associated with promotion and prevention regulatory focus. Cogn Affect
Behav Neurosci 2005, 5:202–211.
Goetz et al. Biology of Mood & Anxiety Disorders 2013, 3:3 Page 10 of 10
http://www.biolmoodanxietydisord.com/content/3/1/340. Barr RS, Pizzagalli DA, Culhane MA, Goff DC, Evins AE: A single dose of
nicotine enhances reward responsiveness in non-smokers: implications
for development of dependence. Biol Psychiatry 2008, 63:1061–1065.
41. Beck AT, Steer RA, Brown GK: Beck Depression Inventory Manual. 2nd edition.
San Antonio: The Psychological Corporation; 1996.
42. Watson D, Clark LA, Tellegen A: Development and validation of brief
measures of positive and negative affect: the PANAS scales. J Pers Soc
Psychol 1988, 54:1063–1070.
43. Tripp G, Alsop B: Sensitivity to reward frequency in boys with attention
deficit hyperactivity disorder. J Clin Child Psychol 1999, 28:366–375.
44. Caspi A, Langley K, Milne B, Moffitt TE, O’Donovan M, Owen MJ, Polo Tomas M,
Poulton R, Rutter M, Taylor A, Williams B, Thapar A: A replicated molecular
genetic basis for subtyping antisocial behavior in children with attention-
deficit/hyperactivity disorder. Arch Gen Psychiatry 2008, 65:203–210.
45. Carver CS, Scheier MF: Self-regulatory perspectives on personality. In
Handbook of psychology: Personality and social psychology, Volume 5. Edited
by Millon T, Lerner MJ. New York: Wiley; 2003,185–208.
46. Hariri AR: The neurobiology of individual differences in complex
behavioral traits. Annu Rev Neurosci 2009, 32:225–247.
doi:10.1186/2045-5380-3-3
Cite this article as: Goetz et al.: Genetic moderation of the association
between regulatory focus and reward responsiveness: a proof-of-
concept study. Biology of Mood & Anxiety Disorders 2013 3:3.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
